Craig Parker has over 25 years of science and business experience from leadership positions in biopharmaceutical and financial companies. Prior to Surrozen, he was Senior Vice President of Corporate Development at Jazz Pharmaceuticals, and also held senior roles at Geron Corporation and Human Genome Sciences. In his early career, he was a top-ranked biotechnology research analyst on Wall Street. Mr. Parker has a bachelor’s degree in biological sciences from the University of Chicago, an MBA from the University of Michigan, and attended Georgetown University School of Medicine.
.svg)
